Research reference

Research Peptide Purity Standards (HPLC/MS) Explained

Purity and identity are the two pillars of peptide batch release. High-performance liquid chromatography (HPLC) and mass spectrometry (MS) are the standard analytical pairing used to verify both before material is approved for dispatch to research laboratories.

What “≥99% purity” means

In peptide supply, purity is almost always reported as area percent on an HPLC chromatogram: the integrated area of the main peptide peak divided by the total integrated area of all detected peaks, multiplied by 100. A result of ≥99% indicates that deletion sequences, truncated analogues, and other synthesis-related impurities together account for less than 1% of detected material under the stated chromatographic method.

This is a relative measure — it depends on the column, gradient, and detection wavelength used. Reputable suppliers document the method or reference a standard operating procedure on the CoA.

HPLC: separating impurities

Reverse-phase HPLC separates peptides by hydrophobicity. Shorter deletion sequences typically elute earlier or later than the full-length product, appearing as distinct peaks. Common impurities include:

• Deletion sequences — peptides missing one or more amino acids from the C- or N-terminus
• Truncated analogues — incomplete synthesis products
• Oxidised variants — particularly for methionine- or cysteine-containing sequences
• Residual reagents — may appear as small early-eluting peaks depending on method

HPLC confirms purity but cannot alone confirm that the main peak is the intended sequence — that requires mass spectrometry.

Mass spectrometry: confirming identity

MS measures the mass-to-charge ratio (m/z) of ionised peptide molecules. For a synthetic peptide, the observed molecular ion (or multiply charged envelope) should match the calculated monoisotopic or average mass of the target sequence, accounting for counter-ions such as trifluoroacetate (TFA) from purification.

Together, HPLC purity and MS identity provide a defensible batch release package for research use. Optimus Peptides specifies ≥99% purity on every catalogue peptide, with batch CoA available on request.

Evaluating supplier claims

When comparing suppliers, look beyond a headline purity figure:

• Is the analytical method described or referenced on the CoA?
• Is MS data included alongside HPLC purity?
• Is the CoA batch-specific (not a generic template)?
• Is third-party testing available for independent verification? See our third-party testing guide.